These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 7600138)

  • 1. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
    Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
    Van der Rijt CC; Schalm SW; Meulstee J; Stijnen T
    Gastroenterol Clin Biol; 1995; 19(6-7):572-80. PubMed ID: 7590022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.
    Strauss E; Tramote R; Silva EP; Caly WR; Honain NZ; Maffei RA; de Sá MF
    Hepatogastroenterology; 1992 Dec; 39(6):542-5. PubMed ID: 1483668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.
    Abid S; Jafri W; Mumtaz K; Islam M; Abbas Z; Shah HA; Hamid S
    J Coll Physicians Surg Pak; 2011 Nov; 21(11):666-71. PubMed ID: 22078345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
    Péroux JL; Paolini O; Tran A; Frappa B; Rampal P
    Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
    Malaguarnera M; Risino C; Cammalleri L; Malaguarnera L; Astuto M; Vecchio I; Rampello L
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
    Bello Mimbrera G; García de León M; de la Torre Gutiérrez S; Montero Vázquez J; Torres Salcines J; de la Torre Fernández JM
    Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
    Ozyilkan E; Kahraman H; Onar M; Kesim G; Arik Z
    East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study.
    Laccetti M; Manes G; Uomo G; Lioniello M; Rabitti PG; Balzano A
    Dig Liver Dis; 2000 May; 32(4):335-8. PubMed ID: 11515632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis.
    Goulenok C; Bernard B; Cadranel JF; Thabut D; Di Martino V; Opolon P; Poynard T
    Aliment Pharmacol Ther; 2002 Mar; 16(3):361-72. PubMed ID: 11876688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial.
    Groeneweg M; Gyr K; Amrein R; Scollo-Lavizzari G; Williams R; Yoo JY; Schalm SW
    Electroencephalogr Clin Neurophysiol; 1996 Jan; 98(1):29-34. PubMed ID: 8689991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial.
    Spahr L; Coeytaux A; Giostra E; Hadengue A; Annoni JM
    Am J Gastroenterol; 2007 Apr; 102(4):744-53. PubMed ID: 17222324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure.
    Devictor D; Tahiri C; Lanchier C; Navelet Y; Durand P; Rousset A
    Intensive Care Med; 1995 Mar; 21(3):253-6. PubMed ID: 7790615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?
    Cadranel JF; Lebiez E; Di Martino V; Bernard B; El Koury S; Tourbah A; Pidoux B; Valla D; Opolon P
    Am J Gastroenterol; 2001 Feb; 96(2):515-8. PubMed ID: 11232699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.